Research Paper Volume 13, Issue 8 pp 11411—11432
Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation
Figure 6. TGLQ decreased the plasma lipid profiles in AS model ApoE-/- mice. (A–D) represent the plasma levels of total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol in each group, respectively. The plasma levels of TC, TG, LDL and HDL were measured using an autoanalyser. Control-group mice were fed with ordinary chow, while the mice of the model group, the low-dose TGLQ-prescription (LTGLQ) group and the high-dose TGLQ-prescription (HTGLQ) group were intragastrically injected with high-fat emulsion and stimulated with chronic stress. LTGLQ and HTGLQ group mice were intragastrically injected with 8.775g/kg and 35.1g/kg TGLQ prescription daily, respectively. #, ##, and ### represent P < 0.05, P < 0.01, and P < 0.001 respectively, in comparison with the control group. *, **, and *** represent P < 0.05, P < 0.01, and P < 0.001 respectively, in comparison with the model group. %% represents P < 0.01, in comparison with the LTGLQ group. n.s represents P > 0.05.